Review



ultrafocus dual energy x ray absorptiometry faxitron quantification  (Faxitron Bioptics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Faxitron Bioptics ultrafocus dual energy x ray absorptiometry faxitron quantification
    DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), <t>ultrafocus</t> <t>dual-energy</t> <t>X-ray</t> <t>absorptiometry-Faxitron</t> quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.
    Ultrafocus Dual Energy X Ray Absorptiometry Faxitron Quantification, supplied by Faxitron Bioptics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ultrafocus+dual+energy+x+ray+absorptiometry+faxitron+quantification/absorptiometry+dual+energy+ray+x/pmc13153612-85-27-30
    Average 86 stars, based on 1 article reviews
    ultrafocus dual energy x ray absorptiometry faxitron quantification - by Bioz Stars, 2026-11
    86/100 stars

    Images

    1) Product Images from "Microenvironmentally derived fatty acid–binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myeloma ∗ "

    Article Title: Microenvironmentally derived fatty acid–binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myeloma ∗

    Journal: Blood Neoplasia

    doi: 10.1016/j.bneo.2026.100229

    DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), ultrafocus dual-energy X-ray absorptiometry-Faxitron quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.
    Figure Legend Snippet: DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), ultrafocus dual-energy X-ray absorptiometry-Faxitron quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.

    Techniques Used: Injection, Comparison

    Related Articles

    Injection:

    Article Title: Microenvironmentally derived fatty acid–binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myeloma
    Article Snippet: .. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), ultrafocus dual-energy X-ray absorptiometry-Faxitron quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). .. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), ultrafocus dual-energy X-ray absorptiometry-Faxitron quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10).



    Similar Products

    ultrafocus dual energy x ray absorptiometry faxitron quantification  (Faxitron Bioptics)
    86
    Faxitron Bioptics ultrafocus dual energy x ray absorptiometry faxitron quantification
    DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), <t>ultrafocus</t> <t>dual-energy</t> <t>X-ray</t> <t>absorptiometry-Faxitron</t> quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.
    Ultrafocus Dual Energy X Ray Absorptiometry Faxitron Quantification, supplied by Faxitron Bioptics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ultrafocus+dual+energy+x+ray+absorptiometry+faxitron+quantification/absorptiometry+dual+energy+ray+x/pmc13153612-85-27-30
    Average 86 stars, based on 1 article reviews
    ultrafocus dual energy x ray absorptiometry faxitron quantification - by Bioz Stars, 2026-11
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), ultrafocus dual-energy X-ray absorptiometry-Faxitron quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.

    Journal: Blood Neoplasia

    Article Title: Microenvironmentally derived fatty acid–binding proteins 4 and 5 are novel therapeutic vulnerabilities in multiple myeloma ∗

    doi: 10.1016/j.bneo.2026.100229

    Figure Lengend Snippet: DIO exacerbates phenotypic differences between WT and Fabp4/5 dKO mice. Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), ultrafocus dual-energy X-ray absorptiometry-Faxitron quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10). Glucose levels assessed during glucose (D) and insulin (E) tolerance testing in WT (n = 10) and Fabp4/5 dKO mice (n = 10); statistical analysis performed using 2-way analysis of variance (ANOVA) and Tukey multiple comparisons tests. AUC for glucose tolerance testing (D) and insulin tolerance testing (E); statistical significance was determined using 2-way ANOVA with Tukey multiple comparison tests for panels B-C, whereas unpaired t tests were used for panels D-E (WT, n = 10; Fabp4/5 dKO , n = 10). AUC, area under the curve; min, minute.

    Article Snippet: Mouse weights over time (A; WT male, n = 9-10; Fabp4/5 dKO male, n = 9-10; WT female, n = 8-10; Fabp4/5 dKO female, n = 10), ultrafocus dual-energy X-ray absorptiometry-Faxitron quantification of total weight (B) and fat weight (C) over the course of HFD administration before tumor cell injection (WT M, n = 9-10; Fabp4/5 dKO M, n = 10; WT F, n = 9-10; Fabp4/5 dKO , n = 10).

    Techniques: Injection, Comparison